|
Hearken to this text  |
The Genesis RMN system is a part of the cardiac program on the College of Kansas Well being System. | Supply: Stereotaxis
Stereotaxis Inc. final week introduced that physicians on the College of Kansas Well being System efficiently handled the primary sufferers with its Genesis system.
The primary use of the Genesis robotic magnetic navigation (RMN) system comes as a part of a robotic coronary heart program on the well being system. Genesis delivers the advantages of robotic precision and security to cardiac ablation to deal with arrhythmias, stated the St. Louis, Mo.-based firm.
“For years, superior robotic expertise has been instrumental in our means to ship superior care to our sufferers, permitting us to navigate advanced cardiac procedures with improved accuracy and security,” stated Dr. Seth Sheldon, cardiac electrophysiologist on the well being system. “The robotic precision and stability provided by the Genesis System permits us to ship exact, personalised therapies to our sufferers, finally enhancing outcomes and high quality of life.”
Genesis makes use of smaller magnets that rotate alongside their middle of mass, permitting for responsiveness to doctor management. The smaller system can enhance the affected person expertise, present higher affected person entry, and improve lab house, stated Stereotaxis.
Versatile, rugged robotic arms maintain the brokers to extend the potential vary of movement and permit for wider X-ray angulation.
Extra about Stereotaxis
A hospital in Kentucky carried out the primary procedures with the Genesis surgical robotic late final yr. Stereotaxis additionally has an ongoing collaboration with Abbott, which had milestone developments final fall.
“We’re proud to proceed our partnership with the well being system to ship distinctive cardiac care to sufferers in Kansas Metropolis,” stated David Fischel, chairman and CEO of Stereotaxis. “We sit up for persevering with to help their profitable and impactful robotic heart-rhythm care program.”
In August, Stereotaxis submitted its next-generation GenesisX system to the U.S. Meals and Drug Administration (FDA) following its receipt of the CE mark in Europe. The corporate stated its expertise has been used to deal with over 150,000 sufferers all over the world.
MassDevice listed Stereotaxis as one of many 10 surgical robotics firms value following in 2024.
Editor’s be aware: This text was syndicated from The Robotic Report sibling website MassDevice.
